Association of Robotic Pleurectomy and Cytoreduction with Hyperthermic Intrathoracic Chemotherapy (HITHOC) for pleural recurrence of Type AB Thymoma

Abstract

Category: Robotic Technology in Thoracic Diseases Introduction: Although usually of an indolent nature, thymoma recurrence rates vary between 15% and 50%.() While surgery remains the cornerstone of treatment, advanced or recurrent thymomas present significant challenges due to their invasive nature and propensity for local recurrence. Hyperthermic intrathoracic chemotherapy (HITHOC) has emerged as a promising adjunctive therapy to address these challenges.(,) This case report presents the utility and outcomes of HITHOC associated with robotic-assisted thoracic surgery (RATS) in the management of [...]